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Background: Hepatic hydrothorax is a major pulmonary complication of liver disease occurring in up to 5-10% of
patients with cirrhosis.
Case presentation: We report four observations of the development of pneumothorax ex-vacuo or trapped lung
in the setting of hepatic hydrothorax. The diagnosis of trapped lung was made based on the presence of a
hydropneumothorax after evacuation of a longstanding hepatic hydrothorax with failure of the lung to re-expand
after chest tube placement in three of the four cases. Two patients underwent surgical decortication with one
subsequent death from post-operative bleeding. The other two patients remarkably had spontaneous improvement
of their “trapped lung” without surgical intervention.
Conclusions: While pneumothorax ex-vacuo is a known phenomenon in malignant effusions, to our knowledge, it
has never been described in association with hepatic hydrothoraces. The pathophysiology of this phenomenon
remains unclear but could be related to chronic inflammation with development of a fibrous layer along the
visceral pleura.
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Hepatic hydrothorax is a major pulmonary complication
of end stage liver disease (ESLD). The diagnosis of hep-
atic hydrothorax can be made in patients with cirrhosis
and portal hypertension who develop large, usually right
sided, pleural effusions in the absence of any primary
cardiac, pulmonary, or pleural disease. Dysregulation of
sodium and fluid management in patients with cirrhosis
leads to the development of ascites. The ascites can then
migrate from the abdomen to the chest through micro-
perforations in the diaphragm leading to a pleural effu-
sion that is transudative by Light’s criteria. This passage
can be further aided by the negative pressure in the
chest generated during inspiration. The prevalence of
hepatic hydrothorax in the setting of cirrhosis ranges
from 5-10% [1-3]. The most cited complications of hep-
atic hydrothorax include respiratory compromise and* Correspondence: ykim@mednet.ucla.edu
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reproduction in any medium, provided the orspontaneous bacterial pleuritis [4]. Management of hep-
atic hydrothorax is generally symptomatic. In mild cases,
sodium restriction and diuretics can be used to minimize
the size of the effusion, supplemented when necessary
by therapeutic thoracenteses. In refractory cases, consid-
eration can be given to transjugular intrahepatic porto-
systemic shunt (TIPS). In this series, we report four
observations of pneumothorax ex-vacuo or trapped lung
associated with hepatic hydrothorax.
Pneumothorax ex-vacuo was first described as the re-
sult of gas being drawn into the pleural space due to
acute endobronchial obstruction with lobar collapse that
is fully reversible once the obstruction is resolved [5].
The definition we have adopted for this case series is the
one described in inflammatory effusions – when the
lung is unable to re-expand after evacuation of pleural
fluid that develops after a remote episode of inflamma-
tion in the setting of a thickened visceral pleura [6,7]. To
our knowledge, pneumothorax ex-vacuo has never been
reported in association with hepatic hydrothoraces.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kim et al. BMC Pulmonary Medicine 2012, 12:78 Page 2 of 6
http://www.biomedcentral.com/1471-2466/12/78Case presentation
Case 1
A 24-year-old male with hepatitis C contracted at birth
developed cirrhosis complicated by variceal bleeding,
portal hypertension, ascites, and a persistent right-sided
hepatic hydrothorax that required thoracenteses every
four to six weeks. The effusions were transudative in na-
ture (fluid to serum total protein ratio 0.4, fluid to serum
LDH ratio 0.5) and without evidence of infection,
pleural, or parenchymal abnormalities consistent with a
hepatic hydrothorax. Given his refractory effusions, an
indwelling pleural cavity drainage catheter was placed at
an outside hospital 8 months prior to his orthotopic liver
transplantation (OLT) for self-drainage of the effusion at
home. The pleural catheter was removed 1 month after
its placement when he was referred for OLT in order to
minimize the chance of infectious complications. He was
subsequently managed successfully with diuretics and
therapeutic thoracenteses as needed for symptomatic re-
lief. At the time of liver transplantation he had under-
gone approximately ten thoracenteses.
He subsequently underwent an uncomplicated OLT. A
pre-operative chest x-ray revealed a large chronic right-
sided pleural effusion. He was successfully extubated
after OLT and doing well so no immediate intervention
was performed on the effusion. On post-operative day
(POD) #5, the patient developed respiratory distress with
new left sided infiltrates consistent with pneumonia. He
was started on antibiotics and a right-sided therapeutic
thoracentesis was performed with removal of 1.3 liters of
fluid. Post-thoracentesis chest imaging revealed a large
hydropneumothorax suspicious for a pneumothorax ex-
vacuo. A small-bore chest tube was inserted and placed
on suction without any additional re-expansion of theFigure 1 Chest x-ray post-OLT: Pneumothorax ex-vacuo. Arrow
indicates location of chest tube.lung or any change in his respiratory status (Figure 1).
The chest tube was discontinued 2 days later and a sub-
sequent chest computed tomography (CT) confirmed
the presence of a large right-sided hydropneumothorax
with underlying visceral and parietal pleural thickening
and fibrosis causing restriction and constriction of the
underlying right lung, consistent with “trapped lung”
(Figure 2). Because there was no evidence of any endo-
bronchial obstruction on CT we elected not to per-
form a diagnostic bronchoscopy to rule out endobronchial
lesions. The patient’s respiratory status improved with
antibiotics and no infection was identified in the pleural
fluid cultures. Thoracic surgery was consulted for pos-
sible video-assisted thoracoscopic surgery (VATS); how-
ever, because the patient was doing well without any
complaints of dyspnea and without hypoxemia, the deci-
sion was made to defer the surgery until his immunosup-
pression was tapered down in order to minimize wound
healing complications. He was discharged home on POD
#20 without need for supplemental oxygen. A repeat
chest x-ray 1 month later showed improvement in the
hydropneumothorax, and a chest x-ray obtained 6 months
later showed near-complete re-expansion of his right lung
without any surgical intervention (Figures 3A-C).
Case 2
A 68-year old female with non-alcoholic steatohepatitis
(NASH) complicated by a refractory right-sided hepatic
hydrothorax (fluid to serum total protein ratio 0.3, fluid
LDH < 2/3 upper limits of normal serum LDH) pre-
sented for an OLT evaluation. The diagnosis of NASH
was made 14 years prior and for the 1 year prior to pres-
entation to our hospital, she had required near weekly
thoracenteses. The patient was subsequently admitted
to our hospital with shortness of breath. Following a
therapeutic thoracentesis, she was noted to have aFigure 2 Chest CT post-OLT: Large right-sided
hydropneumothorax with underlying visceral and parietal
pleural thickening and fibrosis.
Figure 3 Chest x-ray at discharge with a large right-sided hydropneumothorax (A). Chest x-ray at 1 month after discharge with
improvement in the right-sided hydropneumothorax (B). Chest x-ray at 6 months after discharge with significant right lung re-expansion with a
small residual hydropneumothorax (C).
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no air leak or re-expansion of the lung following chest
tube placement. A CT of the chest confirmed the pres-
ence of a hydropneumothorax without evidence of endo-
bronchial obstruction. Thoracic surgery was consulted
to consider her for definitive management of her pleural
effusion because of the persistent high volume drainage
(~700 cc per day) from the chest tube. The patient
underwent VATS decortication and chemical pleurodesis
with resolution of the hydropneumothorax. On POD #20
after her VATS, the patient underwent a successful OLT
and did not suffer any further pulmonary or pleural
complications.
Case 3
A 74-year old male with cirrhosis secondary to hepatitis
B complicated by a refractory right-sided hepatic hydro-
thorax (fluid to serum total protein ratio 0.2, fluid LDH
< 2/3 upper limits of normal serum LDH) requiring near
weekly thoracenteses for the preceding two years pre-
sented for an OLT evaluation. After a thoracentesis, he
was found to have a pneumothorax and a small borechest tube was placed by interventional radiology with-
out subsequent re-expansion of the lung. A bronchos-
copy was performed and did not reveal any endobronchial
abnormalities. Given the complex loculated nature of the
effusion, thoracic surgery recommended a thoracotomy
with decortication. The operation was complicated by sig-
nificant post-operative bleeding, and the patient was
taken back to the operating room 3 days following the
initial thoracotomy due to continued bleeding. Diffuse
oozing was found intra-operatively from the parenchymal
surface of the lung and the chest wall. The patient suf-
fered a cardiac arrest and expired shortly after surgery.
Case 4
A 57-year old male with cirrhosis related to NASH diag-
nosed seven years prior, presented for an OLT evalu-
ation. Prior to presentation, he had multiple chest tubes
placed for a refractory right-sided hepatic hydrothorax
(fluid to serum total protein ratio < 0.5, fluid LDH < 2/3
upper limits of normal serum LDH) with failed attempts
at pleurodesis and had an indwelling pleural cavity
drainage catheter placed at an outside hospital. Due to
Figure 5 Chest x-ray at 1 month after discharge: Significant
right lung re-expansion.
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removed and he was managed with diuretics and fre-
quent thoracenteses. Transjugular intrahepatic porto-
systemic shunt (TIPS) was not initially felt to be an
option secondary to a reported portal vein thrombosis.
Approximately 3 months after the removal of the
pleural catheter, another indwelling pleural catheter was
placed by an outside hospital secondary to the patient’s
difficulty with tolerating diuretics. He eventually under-
went successful TIPS placement for the refractory hep-
atic hydrothorax, and the second indwelling pleural
catheter was removed approximately 2 months after its
placement. After removal of the second indwelling
pleural catheter, chest x-ray revealed a large loculated
hydropneumothorax (Figure 4), suspicious for trapped
lung. Given that the patient remained asymptomatic
without any oxygen requirement, the decision was made
to defer any surgical intervention. He was discharged
from the hospital and a follow-up chest x-ray one month
later revealed significant improvement of his right-sided
hydropneumothorax (Figure 5). He is currently doing
well two years later and continues to await OLT.
Conclusions
Historically, trapped lung was seen in conjunction with
pneumothorax therapy used to treat tuberculosis [6].
Other conditions that have been associated with trapped
lung include parapneumonic effusions, post-cardiac sur-
gery, hemothorax, inflammatory pleuritis, chest radiation,
and malignant pleural effusions [7]. The pathophysiology
of pneumothorax ex-vacuo remains unclear. Several
potential hypotheses have been proposed. The leading
hypothesis involves the formation of a fibrous peel asFigure 4 Chest x-ray after removal of indwelling pleural
catheter showing a large right-sided loculated
hydropneumothorax.the result of chronic inflammation that prevents the lung
from re-expanding [8]. An alternative theory suggests
that the depletion of surfactant, as a result of chronic
atelectasis, is the reason for the lung to fail to re-expand
[9]. In the setting of hepatic hydrothorax, we suspect a
similar pathophysiology involving chronic inflammation
and subsequent development of a fibrous layer along the
visceral pleura. Table 1 summarizes the patient character-
istics of this series. None of our patients had a documen-
ted infectious process in the pleural space at the time of
the trapped lung diagnosis, and no endobronchial abnor-
malities were seen on chest CT or bronchoscopy (when
performed). All patients did have a history of multiple
thoracenteses and two patients had indwelling pleural
cavity drainage catheters placed which could also have
contributed to chronic inflammation and scarring along
the pleura.
Similar to experiences seen with trapped lung in malig-
nant effusions, effective management of trapped lung in
the presence of hepatic hydrothoraces remains extremely
challenging [10]. Chest tube placement in this setting
does not result in lung re-expansion, and surgical inter-
vention can carry significant mortality and morbidity in
patients with ESLD due to their underlying coagulopathy.
Therefore, the ideal management for pneumothorax ex-
vacuo in association with hepatic hydrothorax remains
undefined. In our case series, chest tube placement at
the initial diagnosis of trapped lung did not result in
re-expansion of the lung in any of the patients. Two
patients underwent surgical intervention: one patient
had a successful outcome, while the other patient died
from bleeding complications after thoracic surgery. The
latter case underscores the high-risk nature of thoracic
surgical intervention in this patient population. Finally,
Table 1 Clinical characteristics of patients
Case 1 2 3 4
Age (yrs) 24 68 74 57
Gender M F M M
Race/Ethnicity Hispanic Hispanic Caucasian Middle Eastern
Liver Disease Hepatitis C NASH Hepatitis B NASH
OLT status* Post Pre Pre Pre
Location (Right/Left) R R R R
Previous Indwelling Pleural Catheter (Yes/No) Y N N Y (x 2)
Infection in Pleural Fluid (Yes/No) N N N N
# Thoracenteses Performed ~10 ~5 >10 >15
Chest Tube (Yes/No) Y Y Y N
Response N N N N/A
Surgical Intervention (Yes/No) N Y Y N
Response N/A Y N N/A
Cause of Death N/A N/A Bleeding after thoracic surgery N/A
*at time of diagnosis of trapped lung.
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resolution of their trapped lung without further thor-
acic interventions – one in the setting of immunosup-
pression after a liver transplant and one prior to liver
transplant. The spontaneous improvements in the
hydropneumothoraces suggest a potential for pleural re-
modeling and healing resulting in lung expansion over
time, similar to that seen in some patients with trapped
lung following an empyema.
To our knowledge, this is the first case series reported
of the development of pneumothorax ex-vacuo in associ-
ation with hepatic hydrothorax. Awareness of this
phenomenon is essential in the care and management of
patients with ESLD and recurrent hepatic hydrothoraces.
In asymptomatic patients with pneumothoraces ex-vacuo
in association with hepatic hydrothoraces, observation
with conservative management may be appropriate prior
to surgical interventions, especially in light of the bleed-
ing complications that can occur with liver disease. It
remains unclear whether the development of pneumo-
thorax ex-vacuo would be preventable by keeping the
pleural space as dry as possible to minimize chronic in-
flammation. Additional patients will need to be charac-
terized and followed prospectively to make any further
conclusions on the ideal management of this clinical
dilemma.Consent
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